These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35646691)

  • 1. Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.
    Wang T; Lv Z; Feng H; Li J; Cui B; Yang Y; Huang X; Zhang X; Li X; Ma X
    Front Oncol; 2022; 12():860133. PubMed ID: 35646691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
    Wang C; Sun ZQ; Liu MY; Zhang JJ; Liu G; Feng Y; Yan YF; Cui HW; Li G
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):691-695. PubMed ID: 34289563
    [No Abstract]   [Full Text] [Related]  

  • 3. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
    Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
    Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
    Zhao G; Wang C; Tang Y; Liu X; Liu Z; Li G; Mei Y
    Sci Rep; 2019 Mar; 9(1):5323. PubMed ID: 30926888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis.
    Dutta R; Abdelhalim A; Martin JW; Vernez SL; Faltas B; Lotan Y; Youssef RF
    Urol Oncol; 2016 Dec; 34(12):531.e1-531.e6. PubMed ID: 27427223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
    Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
    Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.
    Mertens LS; Behrendt MA; Mehta AM; Stokkel L; de Jong J; Boot H; Horenblas S; van der Heijden MS; Moonen LM; Aalbers AGJ; Meinhardt W; van Rhijn BWG
    Eur J Surg Oncol; 2019 Sep; 45(9):1740-1744. PubMed ID: 31003721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra.
    Stokkel LE; van Montfoort ML; van Boven HH; Mertens LS; van Rhijn BWG
    Eur Urol Open Sci; 2021 Nov; 33():56-60. PubMed ID: 34622223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
    Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and biological markers in urachal cancer.
    Behrendt MA; van Rhijn BW
    Transl Androl Urol; 2016 Oct; 5(5):655-661. PubMed ID: 27785422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder.
    Xu H; Xie L; Liu X; Zhang Y; Shen Z; Chen T; Qiu X; Sha N; Xing C; Wu Z; Hu H; Wu C
    Oncol Lett; 2017 Sep; 14(3):3522-3528. PubMed ID: 28927108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.
    Behrendt MA; DE Jong J; VAN Rhijn BW
    Minerva Urol Nefrol; 2016 Apr; 68(2):172-84. PubMed ID: 26583595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.